Intrabone administration of unrelated umbilical-cord-blood cells overcomes the problem of graft failure seen with intravenous administration and is associated with a low incidence of graft-versus-host disease*, making the technique potentially useful in a large number of adult
patients with acute leukaemia, according to findings from a phase I/II
study,
published early Online and in the September edition of The Lancet Oncology.